The company said net revenues for Q4 2023 rose 7.4% to $3.704 billion, and net income attributable to UHS was $216.4 million, or $3.16 per diluted share. For Q4 2022, net revenues were $3.447 billion and net income attributable to UHS was $174.8 million, or $2.43 per share.

1. 01

   The company said net revenues for Q4 2023 rose 7.4% to $3.704 billion, and net income attributable to UHS was $216.4 million, or $3.16 per diluted share. For Q4 2022, net revenues were $3.447 billion and net income attributable to UHS was $174.8 million, or $2.43 per share.

2. 02

   UHS said adjusted net income attributable to UHS for 2023 was $739.4 million, or $10.54 per diluted share, and Adjusted EBITDA net of NCI was $1.742 billion. For 2022, the figures were $730.2 million, or $9.88 per share, and $1.662 billion, respectively.

3. 03

   The company said net cash provided by operating activities for 2023 was $1.268 billion, compared with $996 million in 2022. It also said it repurchased approximately 3.86 million shares for about $524.5 million during the year. As of 2023 year-end, the approximate remaining repurchase authorization was $423 million.

4. 04

   Universal Health Services said it expects 2024 net revenues of $15.411 billion to $15.706 billion, Adjusted EBITDA net of NCI of $1.931 billion to $2.019 billion, diluted EPS of $13.00 to $14.00, and capital expenditures of $850 million to $1.000 billion.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the opening part of the filing body and confirmed exhibits, within a length limit. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.